← Leaderboards
William Gregory Hundley
Virginia Commonwealth University
$19,718,962
Attributed
$21,995,565
Total exposure
34
Grants
27
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,995,565 · 34
By mechanism
R01$13,718,649 · 5
T32$2,400,211 · 2
R33$1,791,151 · 2
R21$858,910 · 3
R42$813,754 · 1
R34$601,174 · 1
Top collaborators
- Marie-Pierre Jolly5 shared
- Teresa De Marco3 shared
- Kenneth Alan Ellenbogen3 shared
- Edward Paul Gerstenfeld3 shared
- John Gorcsan3 shared
- Jose Francisco Huizar3 shared
- Carlos Morillo3 shared
- Adam Paul Sima3 shared
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Earl F Ellis$2,975,629
- Steven Grant$20,337,700
Others in their field
Top investigators on “Cardiovascular System”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Judith S. Currier · University Of California Los Angeles$139,907,800
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Judith S Hochman · New York University School Of Medicine$110,228,771
Research focus
Cardiovascular SystemResearch PersonnelMagnetic Resonance ImagingDesignFundingMorbidity - Disease RateProgramsPreventBaseEventInnovationChemotherapyMalignant NeoplasmsFutureImageForestEnrollmentParticipantUnited States National Institutes Of HealthLeftVentricularFunctional DisorderRestPerformance
Grant awards (80)
Supportive Tailored Exercise Program for Survivors of Breast Cancer (STEPS-BC)$671,757
R01 · FY2025 · CA · contact PI
Multi-Disciplinary Training Program in Translational Cardiovascular Research$265,507
T32 · FY2025 · HL · contact PI
Undergraduate Cardiovascular Research Program$123,120
R25 · FY2025 · HL · contact PI
Improving Exercise Capacity with a Tailored Physical Activity Intervention in Lymphoma Patients Undergoing Treatment$337,482
R33 · FY2024 · CA · contact PI
Undergraduate Cardiovascular Research Program$126,360
R25 · FY2024 · HL · contact PI
Multi-Disciplinary Training Program in Translational Cardiovascular Research$1
T32 · FY2024 · HL · contact PI
Multi-Disciplinary Training Program in Translational Cardiovascular Research$396,553
T32 · FY2023 · HL · contact PI
Improving Exercise Capacity with a Tailored Physical Activity Intervention in Lymphoma Patients Undergoing Treatment$350,221
R33 · FY2023 · CA · contact PI
Undergraduate Cardiovascular Research Program$123,120
R25 · FY2023 · HL · contact PI
Multi-Disciplinary Training Program in Translational Cardiovascular Research$479,933
T32 · FY2022 · HL · contact PI
Improving Exercise Capacity with a Tailored Physical Activity Intervention in Lymphoma Patients Undergoing Treatment$386,994
R33 · FY2022 · CA · contact PI
Understanding and Predicting Fatigue, CV Decline & Events After Breast CA Treatment$212,878
R01 · FY2022 · CA · contact PI
Undergraduate Cardiovascular Research Program$99,792
R25 · FY2022 · HL · contact PI
BioImaging Resource Core (BRC)$83,284
P30 · FY2022 · AG · contact PI
Understanding and Predicting Fatigue, CV Decline & Events After Breast CA Treatment$419,244
R01 · FY2021 · CA · contact PI
Multi-Disciplinary Training Program in Translational Cardiovascular Research$369,061
T32 · FY2021 · HL · contact PI
BioImaging Resource Core (BRC)$81,206
P30 · FY2021 · AG · contact PI
Multi-Disciplinary Training Program in Translational Cardiovascular Research$181,887
T32 · FY2020 · HL · contact PI
Improving Exercise Capacity with a Tailored Physical Activity Intervention in Lymphoma Patients Undergoing Treatment$179,459
R21 · FY2020 · CA · contact PI
BioImaging Resource Core (BRC)$79,795
P30 · FY2020 · AG · contact PI
Understanding and Predicting Fatigue, CV Decline & Events After Breast CA Treatment$617,373
R01 · FY2019 · CA · contact PI
Improving Exercise Capacity with a Tailored Physical Activity Intervention in Lymphoma Patients Undergoing Treatment$193,301
R21 · FY2019 · CA · contact PI
Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy(PAPS): A Pilot Study$166,124
R34 · FY2019 · HL
BioImaging Resource Core (BRC)$81,509
P30 · FY2019 · AG · contact PI
Preventing Anthracycline Cardiovascular Toxicity with Statins$710,593
R01 · FY2018 · HL · contact PI
Understanding and Predicting Fatigue, CV Decline & Events After Breast CA Treatment$635,180
R01 · FY2018 · CA · contact PI
Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy(PAPS): A Pilot Study$199,003
R34 · FY2018 · HL
Preventing Anthracycline Cardiovascular Toxicity with Statins$106,536
R01 · FY2018 · HL · contact PI
BioImaging Resource Core (BRC)$81,037
P30 · FY2018 · AG · contact PI
Preventing Anthracycline Cardiovascular Toxicity with Statins$896,071
R01 · FY2017 · HL · contact PI
Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy(PAPS): A Pilot Study$236,047
R34 · FY2017 · HL
Preventing Anthracycline Cardiovascular Toxicity with Statins$900,665
R01 · FY2016 · HL · contact PI
Understanding and Predicting Fatigue, CV Decline & Events After Breast CA Treatment$638,913
R01 · FY2016 · CA · contact PI
Early Imaging Detection of CV Injury after Cancer$502,024
R01 · FY2016 · CA · contact PI
Understanding and Predicting Fatigue, CV Decline & Events After Breast CA Treatment$650,504
R01 · FY2015 · CA · contact PI
Early Imaging Detection of CV Injury after Cancer$506,158
R01 · FY2015 · CA · contact PI
Preventing Anthracycline Cardiovascular Toxicity with Statins$875,689
R01 · FY2014 · HL · contact PI
Early Imaging Detection of CV Injury after Cancer$494,327
R01 · FY2014 · CA · contact PI
Preventing Anthracycline Cardiovascular Toxicity with Statins$23,435
R01 · FY2014 · HL · contact PI
Preventing Anthracycline Cardiovascular Toxicity with Statins$719,147
R01 · FY2013 · HL · contact PI
Early Imaging Detection of CV Injury after Cancer$478,909
R01 · FY2013 · CA · contact PI
Advanced Non-Contrast Imaging for Cardiotoxicity Detection after Cancer$299,724
R43 · FY2013 · CA
Multidisciplinary Training in Cardiovascular Imaging$1
T32 · FY2013 · HL · contact PI
Early Imaging Detection of CV Injury after Cancer$493,241
R01 · FY2012 · CA · contact PI
Multidisciplinary Training in Cardiovascular Imaging$246,068
T32 · FY2012 · HL · contact PI
Vascular Stiffness and Pulmonary Congestion$585,362
R01 · FY2011 · HL · contact PI
Comprehensive MR Imaging of Elderly Vascular Function: Phase II$409,814
R42 · FY2011 · AG · contact PI
Multidisciplinary Training in Cardiovascular Imaging$146,264
T32 · FY2011 · HL · contact PI
Vascular Stiffness and Pulmonary Congestion$591,099
R01 · FY2010 · HL · contact PI
Comprehensive MR Imaging of Elderly Vascular Function: Phase II$403,940
R42 · FY2010 · AG · contact PI
Multidisciplinary Training in Cardiovascular Imaging$239,802
T32 · FY2010 · HL · contact PI
PULMONARY CONGESTION AND VASCULAR STIFFNESS (PREDICT)$96,926
M01 · FY2010 · RR · contact PI
PREDICTION OF CHEMOTHERAPY INDUCED CARDIOMYOPATHY WITH MRI DETECT I$58,848
M01 · FY2010 · RR · contact PI
DETECT III$17,885
M01 · FY2010 · RR · contact PI
COMPARISON OF DOBUTAMINE AND REGADENOSON STRESS CMR$9,231
M01 · FY2010 · RR · contact PI
Vascular Stiffness and Pulmonary Congestion$666,194
R01 · FY2009 · HL · contact PI
Optimized CMR imaging of chemotherapy cardiotoxicity$227,111
R33 · FY2009 · CA · contact PI
PULMONARY CONGESTION AND VASCULAR STIFFNESS (PREDICT)$114,364
M01 · FY2009 · RR · contact PI
PREDICTION OF CHEMOTHERAPY INDUCED CARDIOMYOPATHY WITH MRI DETECT I$81,758
M01 · FY2009 · RR · contact PI
Multidisciplinary Training in Cardiovascular Imaging$75,134
T32 · FY2009 · HL · contact PI
COMPARISON OF DOBUTAMINE AND REGADENOSON STRESS CMR$974
M01 · FY2009 · RR · contact PI
Vascular Stiffness and Pulmonary Congestion$659,037
R01 · FY2008 · HL · contact PI
Optimized CMR imaging of chemotherapy cardiotoxicity$244,400
R33 · FY2008 · CA · contact PI
Comprehensive MR Imaging of Elderly Vascular Function$99,985
R41 · FY2008 · AG · contact PI
PULMONARY CONGESTION AND VASCULAR STIFFNESS (PREDICT)$70,710
M01 · FY2008 · RR · contact PI
PREDICTION OF CHEMOTHERAPY INDUCED CARDIOMYOPATHY WITH MRI$10,839
M01 · FY2008 · RR · contact PI
Vascular Stiffness and Pulmonary Congestion$664,313
R01 · FY2007 · HL · contact PI
Optimized CMR imaging of chemotherapy cardiotoxicity$244,943
R33 · FY2007 · CA · contact PI
MRI Detection of Doxorubicin Induced Cardiotoxicity$132,372
R21 · FY2007 · CA · contact PI
VASCULAR STIFFNESS IN PULMONARY CONGESTION IN CHF$5,298
M01 · FY2007 · RR · contact PI
Optimized CMR imaging of chemotherapy cardiotoxicity$193,287
R21 · FY2006 · CA · contact PI
MRI Detection of Doxorubicin Induced Cardiotoxicity$160,491
R21 · FY2006 · CA · contact PI
VASCULAR STIFFNESS IN PULMONARY CONGESTION IN CHF$11,376
M01 · FY2006 · RR · contact PI
ARTERIAL BLOOD FLOW RESPONSE DURING SUBMAXIMAL EXERCISE MEASURE WITH MRI$17,347
M01 · FY2005 · RR
PREDICTION OF CHEMOTHERAPY INDUCED CARDIOMYOPATHY WITH MRI$6,769
M01 · FY2005 · RR
VASCULAR STIFFNESS IN PULMONARY CONGESTION IN CHF$1,269
M01 · FY2005 · RR
Vasomotor Effect of Hormonal Replacement Regimens$25,906
M01 · FY2004 · RR
Prediction of Chemotherapy Induced Cardiomyopathy with MRI$2,189
M01 · FY2004 · RR
Arterial Blood Flow Response during Submaximal Exercise Measure with MRI$1,095
M01 · FY2004 · RR
LEG BLOOD FLOW, SARCOPENIA AND PHYSICAL FUNCTION$0
P30 · FY2002 · AG